Security key
128058302
- Security type / class
- Equity / COM
- Total 13F shares
- 702,854
- Total 13F value
- $1,307,418
- Share change
- +215
- SEC-reported price per share
- $1.86
- Number of holders
- 25
- Value change
- -$8,228
- Number of buys
- 12
- Number of sells
- 8
Report period
Q4 2025
Institutions
25
Top holders
10
LSTA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
LISATA THERAPEUTICS, INC. SEC filings
LISATA THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 128058302
Recent filing periods:
Ownership snapshot
Top reported holders of LSTA - LISATA THERAPEUTICS, INC. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Erkki Ruoslahti
Disclosed value leader
Erkki Ruoslahti
Comparable rows
0/15
Latest evidence
30 Sep 2025
3/4/5
13F
Highest disclosed value: $3,561,521
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Erkki Ruoslahti has the largest disclosed position value at $3.56M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Erkki Ruoslahti's linked filing trail.
Disclosed position value
Top 5
Erkki Ruoslahti
$3.56M
VANGUARD GROUP INC
$708.7K
Steven S. Myers
$668.1K
Michael H. Davidson
$627.2K
Anne Clem Whitaker
$546.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Erkki Ruoslahti |
3/4/5
Director
|
—
class O/S missing
|
$3,561,521
1,191,144 shares
|
— | 09 Jan 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$708,747
270,514 shares
|
— | 30 Sep 2025 |
| Steven S. Myers |
3/4/5
Director
|
—
class O/S missing
|
$668,142
223,459 shares
|
— | 10 Jan 2022 |
| Michael H. Davidson |
3/4/5
Director
|
—
class O/S missing
|
$627,161
209,753 shares
|
— | 10 Jan 2022 |
| Anne Clem Whitaker |
3/4/5
Director
|
—
class O/S missing
|
$546,079
182,635 shares
|
— | 10 Jan 2022 |
| Todd C. Girolamo |
3/4/5
CLO, SVP of Corp Dev
|
—
class O/S missing
|
$480,873
160,827 shares
|
— | 13 Jan 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
25
Shares
702,854
Rows available
25
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
21
Q4 2025 holders
25
Holder diff
4
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend